ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
August 09 2021 - 8:30AM
ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical
science and technology company, will hold a conference call on
Friday, August 13, 2021 at 11:00 a.m. Eastern time to discuss its
results for the second quarter ended June 30, 2021. A press release
detailing these results will be issued prior to the call.
ProPhase Labs’ CEO and Chairman of the Board of
Directors, Ted Karkus, will host the conference call, followed by a
question-and-answer period.
To access the call, please use the following
information:
Date: |
Friday, August 13, 2021 |
Time: |
11:00 a.m. Eastern time, 8:00 a.m. Pacific time |
Participants can register for the conference call
by navigating
to: https://dpregister.com/sreg/10159437/ec3cd8f253
Please note that registered participants will
receive their dial in number upon registration. Pre-registration
required fields of information include: name, phone, company,
email.
Those without internet access or unable to
pre-register may dial in to the conference call by calling:
Toll free dial in
number: |
1-866-777-2509 |
International dial in
number: |
1-412-317-5413 |
Please call the conference telephone number 5-10
minutes prior to the start time. Please ask to be joined into the
ProPhase Labs, Inc. conference call. An operator will register your
name, phone and organization. If you have any difficulty connecting
with the conference call, please contact CORE IR at
516-222-2560.
The conference call will be broadcast live and
available for replay at
https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs
and via the investor relations section of the Company's website at
www.ProPhaseLabs.com.
A replay of the conference call will be
available two hours from the calls end.
Toll-free replay
number: |
1-877-344-7529 |
International replay
number: |
1-412-317-0088 |
Replay Access
Code: |
10159437 |
About ProPhase Labs
ProPhase Labs (Nasdaq: PRPH) (“ProPhase”) is a
diversified medical science and technology company. The Company’s
subsidiary, ProPhase Diagnostics, offers a broad array of clinical
diagnostic and testing services at its CLIA certified laboratories.
ProPhase Diagnostics serves patients with SARS-CoV-2 (COVID-19)
through both saliva and nasal swab methods. Critical to COVID
testing, results are provided in under 24 hours. ProPhase also
offers PCR (polymerase chain reaction) testing for Influenzas A and
B and RSV. ProPhase Diagnostics also now offers antigen and
antibody/immunity tests in partnership with scientists to broaden
its COVID-19 testing beyond RT-PCR testing. ProPhase Labs
researches, develops, manufactures, distributes, markets, and sells
OTC consumer healthcare products and dietary supplements, including
dietary supplements under the TK Supplements® brand. ProPhase
actively pursues strategic investments and acquisition
opportunities for other companies, technologies, and products. For
more information,
visit www.ProPhaseLabs.com.
Investor
Contact: CORE
IRJules Abraham917-885-7378julesa@coreir.com
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2023 to Apr 2024